| Ytd | 22.21% | |
| 1y | 171.74% |
| Open | 25.81 | Prev Close | 25.69 | Low | 25.42 | High | 26.47 | Mkt Cap | 2.51B |
| Vol | 872.38K | Avg Vol | 1.39M | EPS | -2.38 | P/E | -11.03 | Forward P/E | -12.12 |
| Beta | 2.12 | Short Ratio | 9.26 | Inst. Own | 108.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 21.59 | 200-d Avg | 21.23 | 1yr Est | 35.77 |
IMNM News
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology comp
U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 reve
Atika Capital Management LLC lessened its holdings in Immunome, Inc. (NASDAQ: IMNM) by 21.4% in the
Wedbush analyst David Nierengarten reiterates Immunome (NASDAQ:IMNM) with a Outperform and mainta
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to
An Immunome insider sold 100,000 shares for $2.4 million based on weighted average prices on July 6,
IMNM jumps 32% in a month. This comes as the FDA accepts varegacestat's NDA for desmoid tumors, with
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology comp
[url="]Immunome, Inc.[/url] (Nasdaq: IMNM), a biotechnology company committed to developing first-in
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to
Immunome, Inc. (IMNM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transc
Immunome is evolving into a multi-asset targeted oncology platform, anchored by varegacestat's stron
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedica
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology comp
[url="]Immunome, Inc.[/url] (Nasdaq: IMNM), a biotechnology company committed to developing first-in
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to
[url="]Immunome[/url], Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-c
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on d
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on d
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology comp
BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to
On Wednesday, 807 companies reached new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week
On Monday, 524 stocks hit new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.
On Friday, 313 companies hit new 52-week lows.
During Wednesday's morning trading, 400 companies set new 52-week lows.
Tuesday morning saw 454 companies set new 52-week lows.
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-m
Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET on Friday, 202 companies set new 52-we
This morning 533 companies reached new 52-week highs.
Before 10 a.m. ET on Wednesday, 192 companies set new 52-week highs.
On Tuesday morning, 172 companies achieved new highs for the year.
Gainers Zomedica Corp. (NYSE: ZOM) shares surged 92.2% to close at $0.93 on Monday after surging